This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Biolegend, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Takatoku Oida: Innovator in Anti-TLR7 Agents
Introduction
Takatoku Oida is a notable inventor based in San Diego, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of anti-TLR7 agents. His work is crucial in advancing therapeutic options for various medical conditions.
Latest Patents
Oida holds a patent titled "ANTI-TLR7 AGENTS AND COMPOSITIONS AND METHODS FOR MAKING AND USING THE SAME." This patent represents his innovative approach to addressing challenges in immunology and therapeutic development. He has 1 patent to his name, showcasing his expertise and commitment to research.
Career Highlights
Currently, Takatoku Oida is employed at BioLegend, Inc., a company known for its contributions to life sciences and biotechnology. His role at BioLegend allows him to collaborate with other talented professionals in the field, further enhancing his impact on scientific research.
Collaborations
Some of his coworkers include Anagha Ashok Divekar and Shawna Ann Shirley. Their collaboration fosters a dynamic environment for innovation and discovery within the company.
Conclusion
Takatoku Oida's work in developing anti-TLR7 agents exemplifies the importance of innovation in biotechnology. His contributions are paving the way for new therapeutic strategies and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile